Release Date: 19/04/24 16:18 Summary: Quarterly Activities/Appendix 4C Cash Flow Report Price Sensitive: Yes Download Document 305.96KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status